Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. (Q38162576)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

meta-analysis

0 references

title

Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

human subject research project

29 February 2020

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Melinda T Coughlan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Christopher M Reid

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

13 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Nutrition

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1147-1161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Added soluble fiber enhances the satiating power of low-energy-density liquid yogurts

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The gut microbiota as an environmental factor that regulates fat storage

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Butyrate improves insulin sensitivity and increases energy expenditure in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The role of the gut microbiota in nutrition and health.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Appetite during consumption of enteral formula as a sole source of nutrition: the effect of supplementing pea-fibre and fructo-oligosaccharides

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The inclusion of a partial meal replacement with or without inulin to a calorie restricted diet contributes to reach recommended intakes of micronutrients and decrease plasma triglycerides: a randomized clinical trial in obese Mexican women

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Yacon syrup: beneficial effects on obesity and insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The food additives inulin and stevioside counteract oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Oligofructose promotes satiety in healthy human: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effects of prebiotics on the immune response to vaccination in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The immune-enhancing effects of dietary fibres and prebiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Probiotics and gut health: a special focus on liver diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Probiotics and liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Should immunonutrition become routine in critically ill patients? A systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Role of dietary beta-glucans in the prevention of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

The gut microbiota and lipid metabolism: implications for human health and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Intestinal health functions of colonic microbial metabolites: a review

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Arabinoxylan fibre improves metabolic control in people with Type II diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Interaction between obesity and the gut microbiota: relevance in nutrition

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Comment on: Jowett et al. (2010) Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes;59:726-732

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Effect of lipopolysaccharide on inflammation and insulin action in human muscle

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Metabolic diseases and pro- and prebiotics: Mechanistic insights

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Microbiota-stimulated immune mechanisms to maintain gut homeostasis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Postprandial metabolic events and fruit-derived phenolics: a review of the science

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Molecular characterisation of the faecal microbiota in patients with type II diabetes.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

Human oral, gut, and plaque microbiota in patients with atherosclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003607

7 January 2021

10.1017/S0007114513003607

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24230488%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference